Annual Total Expenses
$226.85 M
-$52.45 M-18.78%
December 31, 2023
Summary
- As of February 8, 2025, FBIO annual total expenses is $226.85 million, with the most recent change of -$52.45 million (-18.78%) on December 31, 2023.
- During the last 3 years, FBIO annual total expenses has risen by +$86.99 million (+62.19%).
- FBIO annual total expenses is now -18.78% below its all-time high of $279.31 million, reached on December 31, 2022.
Performance
FBIO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$36.72 M
-$3.31 M-8.27%
September 30, 2024
Summary
- As of February 8, 2025, FBIO quarterly total expenses is $36.72 million, with the most recent change of -$3.31 million (-8.27%) on September 30, 2024.
- Over the past year, FBIO quarterly total expenses has dropped by -$11.79 million (-24.30%).
- FBIO quarterly total expenses is now -54.25% below its all-time high of $80.28 million, reached on December 31, 2021.
Performance
FBIO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
FBIO Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.8% | -24.3% |
| 3 y3 years | +62.2% | -54.3% |
| 5 y5 years | +54.5% | +12.9% |
FBIO Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.8% | at low | -54.3% | at low |
| 5 y | 5-year | -18.8% | +62.2% | -54.3% | +12.9% |
| alltime | all time | -18.8% | +2354.9% | -54.3% | +133.8% |
Fortress Biotech Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $36.72 M(-8.3%) |
| Jun 2024 | - | $40.03 M(-19.3%) |
| Mar 2024 | - | $49.60 M(+16.1%) |
| Dec 2023 | $226.85 M(-18.8%) | $42.70 M(-12.0%) |
| Sep 2023 | - | $48.51 M(-24.6%) |
| Jun 2023 | - | $64.35 M(-9.7%) |
| Mar 2023 | - | $71.30 M(+0.4%) |
| Dec 2022 | $279.31 M(+12.7%) | $71.04 M(+5.6%) |
| Sep 2022 | - | $67.26 M(-3.7%) |
| Jun 2022 | - | $69.81 M(-1.9%) |
| Mar 2022 | - | $71.19 M(-11.3%) |
| Dec 2021 | $247.79 M(+77.2%) | $80.28 M(+30.6%) |
| Sep 2021 | - | $61.47 M(+1.3%) |
| Jun 2021 | - | $60.70 M(+45.9%) |
| Mar 2021 | - | $41.60 M(+9.3%) |
| Dec 2020 | $139.87 M(-5.1%) | $38.05 M(+17.0%) |
| Sep 2020 | - | $32.52 M(-6.7%) |
| Jun 2020 | - | $34.85 M(+1.2%) |
| Mar 2020 | - | $34.45 M(-17.0%) |
| Dec 2019 | $147.45 M(+0.4%) | $41.51 M(+28.5%) |
| Sep 2019 | - | $32.31 M(-6.5%) |
| Jun 2019 | - | $34.54 M(-11.6%) |
| Mar 2019 | - | $39.09 M(-5.2%) |
| Dec 2018 | $146.88 M(+37.2%) | $41.21 M(+23.5%) |
| Sep 2018 | - | $33.38 M(+3.6%) |
| Jun 2018 | - | $32.21 M(-19.6%) |
| Mar 2018 | - | $40.08 M(-136.9%) |
| Dec 2017 | $107.04 M | -$108.60 M(-236.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $79.49 M(+7.6%) |
| Jun 2017 | - | $73.89 M(+18.7%) |
| Mar 2017 | - | $62.26 M(+95.5%) |
| Dec 2016 | $82.19 M(+59.9%) | $31.85 M(+85.0%) |
| Sep 2016 | - | $17.22 M(-0.8%) |
| Jun 2016 | - | $17.37 M(+10.3%) |
| Mar 2016 | - | $15.75 M(+21.5%) |
| Dec 2015 | $51.39 M(+148.9%) | $12.96 M(-28.4%) |
| Sep 2015 | - | $18.10 M(+133.1%) |
| Jun 2015 | - | $7.76 M(-38.3%) |
| Mar 2015 | - | $12.57 M(+153.4%) |
| Dec 2014 | $20.65 M(-42.3%) | $4.96 M(+14.2%) |
| Sep 2014 | - | $4.35 M(-8.8%) |
| Jun 2014 | - | $4.76 M(-27.6%) |
| Mar 2014 | - | $6.58 M(-30.9%) |
| Dec 2013 | $35.78 M(+31.7%) | $9.52 M(+26.9%) |
| Sep 2013 | - | $7.50 M(-27.1%) |
| Jun 2013 | - | $10.29 M(+21.7%) |
| Mar 2013 | - | $8.46 M(+1.9%) |
| Dec 2012 | $27.18 M(-22.5%) | $8.30 M(+42.3%) |
| Sep 2012 | - | $5.83 M(-9.8%) |
| Jun 2012 | - | $6.46 M(-1.8%) |
| Mar 2012 | - | $6.58 M(+25.8%) |
| Dec 2011 | $35.04 M(+279.2%) | $5.23 M(+48.2%) |
| Sep 2011 | - | $3.53 M(-5.5%) |
| Jun 2011 | - | $3.74 M(-83.4%) |
| Mar 2011 | - | $22.55 M(+843.3%) |
| Dec 2010 | $9.24 M | $2.39 M(+14.8%) |
| Sep 2010 | - | $2.08 M |
FAQ
- What is Fortress Biotech annual total expenses?
- What is the all time high annual total expenses for Fortress Biotech?
- What is Fortress Biotech annual total expenses year-on-year change?
- What is Fortress Biotech quarterly total expenses?
- What is the all time high quarterly total expenses for Fortress Biotech?
- What is Fortress Biotech quarterly total expenses year-on-year change?
What is Fortress Biotech annual total expenses?
The current annual total expenses of FBIO is $226.85 M
What is the all time high annual total expenses for Fortress Biotech?
Fortress Biotech all-time high annual total expenses is $279.31 M
What is Fortress Biotech annual total expenses year-on-year change?
Over the past year, FBIO annual total expenses has changed by -$52.45 M (-18.78%)
What is Fortress Biotech quarterly total expenses?
The current quarterly total expenses of FBIO is $36.72 M
What is the all time high quarterly total expenses for Fortress Biotech?
Fortress Biotech all-time high quarterly total expenses is $80.28 M
What is Fortress Biotech quarterly total expenses year-on-year change?
Over the past year, FBIO quarterly total expenses has changed by -$11.79 M (-24.30%)